Moreover, elevated levels of IL-35 in osteosarcoma patients inhibited the antitumor ability of CD8+ T cells, with Treg-secreted IL-35 related to the suppression of CD8+ T cell function (Liu MX. Here, CD8A is linked to osteosarcoma.